In continuation of my update on  Tivozanib AVEO Oncology (Nasdaq: AVEO)   announced  the U.S. Food and Drug Administration (FDA)   approval ...

Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today...

In continuation of my update on Lansoprazole Lansoprazole, an over-the-counter  acid reflux  drug that is often taken by pregnant women, may...

Antibiotic resistance is a growing public health problem across the globe, with many diseases becoming harder to treat. Now, a newly disc...

Harmine Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, togethe...

Maternal factors, such as breast milk, have been shown to affect a baby's development, and previous animal studies have determined that ...

In continuation of my update on aspirin The increased risk of heart attack or "a broken heart" in early bereavement could be reduc...

In continuation of my update on metformin Among high-risk prostate cancer patients - those with high PSA and Gleason scores of 8 or more...

In continuation of  my update on metformin A team of researchers from University of California, San Diego, have successfully used gut organo...

In continuation of my update on Rosiglitazone Rosiglitazone seems to be associated with an increased cardiovascular risk, particularly...

The concept is based on the interaction of resonant semiconductor iron oxide Fe2O3 nanoparticles with light. Particles previously loaded wit...

Researchers from Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center (UH), Cleveland Clinic an...